A new trading day began on Tuesday, with Plus Therapeutics Inc (NASDAQ: PSTV) stock price up 7.32% from the previous day of trading, before settling in for the closing price of $0.48. PSTV’s price has ranged from $0.16 to $2.31 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 46.51% over the past five years. Meanwhile, its annual earnings per share averaged 87.69%. With a float of $136.95 million, this company’s outstanding shares have now reached $137.43 million.
Plus Therapeutics Inc (PSTV) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Plus Therapeutics Inc is 0.35%, while institutional ownership is 5.82%. The most recent insider transaction that took place on Nov 04 ’25, was worth 10,200. In this transaction Chief Financial Officer of this company bought 20,000 shares at a rate of $0.51, taking the stock ownership to the 68,138 shares. Before that another transaction happened on Aug 22 ’25, when Company’s Director bought 110,000 for $0.49, making the entire transaction worth $53,779. This insider now owns 139,327 shares in total.
Plus Therapeutics Inc (PSTV) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.49 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 87.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 62.04% during the next five years compared to 46.51% growth over the previous five years of trading.
Plus Therapeutics Inc (NASDAQ: PSTV) Trading Performance Indicators
Here are Plus Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.90, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of Plus Therapeutics Inc (PSTV)
Plus Therapeutics Inc (NASDAQ: PSTV) saw its 5-day average volume 4.09 million, a negative change from its year-to-date volume of 19.36 million. As of the previous 9 days, the stock’s Stochastic %D was 26.59%.
During the past 100 days, Plus Therapeutics Inc’s (PSTV) raw stochastic average was set at 36.00%, which indicates a significant decrease from 42.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0489 in the past 14 days, which was lower than the 0.0667 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5767, while its 200-day Moving Average is $0.6353. Nevertheless, the first resistance level for the watch stands at $0.5269 in the near term. At $0.5437, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5684. If the price goes on to break the first support level at $0.4854, it is likely to go to the next support level at $0.4607. Assuming the price breaks the second support level, the third support level stands at $0.4439.
Plus Therapeutics Inc (NASDAQ: PSTV) Key Stats
With a market capitalization of 70.10 million, the company has a total of 137,429K Shares Outstanding. Currently, annual sales are 5,820 K while annual income is -12,980 K. The company’s previous quarter sales were 1,400 K while its latest quarter income was -4,420 K.
